An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Mar 2023
Historique:
received: 11 02 2023
revised: 03 03 2023
accepted: 04 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Secretin-stimulated pancreatic juice (PJ), collected from the duodenum, presents a valuable biomarker source for the (earlier) detection of pancreatic cancer (PC). Here, we evaluate the feasibility and performance of shallow sequencing to detect copy number variations (CNVs) in cell-free DNA (cfDNA) from PJ for PC detection. First, we confirmed the feasibility of shallow sequencing in PJ (n = 4), matched plasma (n = 3) and tissue samples (n = 4, microarray). Subsequently, shallow sequencing was performed on cfDNA from PJ of 26 cases (25 sporadic PC, 1 high-grade dysplasia) and 19 controls with a hereditary or familial increased risk of PC. 40 of the 45 PJ samples met the quality criteria for cfDNA analysis. Nine individuals had an 8q24 gain (oncogene MYC; 23%; eight cases (33%) and one control (6%),

Identifiants

pubmed: 36982172
pii: ijms24065097
doi: 10.3390/ijms24065097
pmc: PMC10049288
pii:
doi:

Substances chimiques

Biomarkers 0
Cell-Free Nucleic Acids 0
Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Br J Cancer. 2016 Feb 2;114(3):269-80
pubmed: 26766740
Gut. 2022 Jun;71(6):1152-1160
pubmed: 33820756
PLoS Genet. 2016 Jul 18;12(7):e1006162
pubmed: 27428049
Oncol Lett. 2017 Dec;14(6):7849-7861
pubmed: 29344231
Cytokine. 2017 Jan;89:12-20
pubmed: 26631912
Histopathology. 2019 Oct;75(4):546-551
pubmed: 31054158
Prenat Diagn. 2015 Aug;35(8):810-5
pubmed: 25967380
Biochim Biophys Acta. 2000 Oct 18;1502(2):283-96
pubmed: 11040453
J Clin Oncol. 2022 Aug 1;40(22):2426-2435
pubmed: 35394817
JCI Insight. 2017 Oct 5;2(19):
pubmed: 28978805
Dokl Biochem Biophys. 2017 Jul;475(1):250-252
pubmed: 28864900
Am J Gastroenterol. 2020 Dec;115(12):2103-2108
pubmed: 33105193
JAMA. 2015 Jul 14;314(2):162-9
pubmed: 26168314
Oncogene. 2022 May;41(20):2811-2823
pubmed: 35418690
Oncotarget. 2016 Apr 26;7(17):24719-33
pubmed: 27034160
J Pathol. 2000 May;191(1):27-32
pubmed: 10767715
Cancer Med. 2019 Aug;8(10):4565-4573
pubmed: 31225717
NPJ Precis Oncol. 2022 Sep 6;6(1):63
pubmed: 36068285
Gastroenterology. 2012 Sep;143(3):821-831.e2
pubmed: 22609312
Oncotarget. 2017 Apr 25;8(17):28558-28574
pubmed: 28212566
Oncotarget. 2017 Mar 7;8(10):16704-16711
pubmed: 28053288
Ther Adv Med Oncol. 2020 May 08;12:1758835920917558
pubmed: 32426049
Gastroenterology. 2022 Apr;162(4):1319-1333
pubmed: 34999097
Clin Case Rep. 2022 Oct 11;10(10):e6280
pubmed: 36245448
Nature. 2015 Feb 26;518(7540):495-501
pubmed: 25719666
Sci Transl Med. 2018 Nov 7;10(466):
pubmed: 30404863
Pancreatology. 2001;1(3):254-62
pubmed: 12120204
Cell Death Differ. 2006 Aug;13(8):1256-9
pubmed: 16710363
Nat Commun. 2015 Apr 09;6:6744
pubmed: 25855536
BMC Cancer. 2011 Jun 13;11:245
pubmed: 21668992
Nucleic Acids Res. 1981 Sep 11;9(17):4267-83
pubmed: 6272202
Nature. 2011 Jul 06;475(7354):106-9
pubmed: 21734707
Oncogene. 2022 Feb;41(6):838-851
pubmed: 34975151
Nat Rev Dis Primers. 2016 Apr 21;2:16022
pubmed: 27158978
Carcinogenesis. 2015 Jul;36(7):730-8
pubmed: 25939753
Elife. 2015 Jul 07;4:
pubmed: 26151762
Br J Cancer. 2020 May;122(10):1486-1495
pubmed: 32203220
Mod Pathol. 2002 Apr;15(4):462-9
pubmed: 11950922
Ann Oncol. 2015 Sep;26 Suppl 5:v56-68
pubmed: 26314780
J Exp Clin Cancer Res. 2017 May 8;36(1):64
pubmed: 28482903
Therap Adv Gastroenterol. 2021 May 10;14:17562848211014818
pubmed: 34025781
Genes Chromosomes Cancer. 2017 May;56(5):427-435
pubmed: 28124395
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7101-6
pubmed: 19372370
EBioMedicine. 2021 Dec;74:103716
pubmed: 34839264
Metallomics. 2020 Dec 23;12(12):2121-2133
pubmed: 33295928
World J Gastroenterol. 2012 Feb 28;18(8):840-6
pubmed: 22371645
Curr Cancer Drug Targets. 2019;19(7):515-524
pubmed: 30338738
Sci Rep. 2016 Nov 04;6:36097
pubmed: 27811968
Clin Cancer Res. 2011 Jan 15;17(2):302-9
pubmed: 21098698
Cancer Res. 2019 Jan 1;79(1):220-230
pubmed: 30389699
Biochem J. 2013 May 1;451(3):395-405
pubmed: 23339455
Am J Hum Genet. 2020 Feb 6;106(2):202-214
pubmed: 32004449
World J Surg Oncol. 2015 Feb 21;13:66
pubmed: 25880226
Am J Pathol. 2018 Jul;188(7):1723-1733
pubmed: 29684357
Mol Oncol. 2018 Jun;12(7):1104-1124
pubmed: 29719936
J Gastrointest Surg. 2008 Oct;12(10):1664-72; discussion 1672-3
pubmed: 18677542
JAMA Oncol. 2015 Sep;1(6):814-9
pubmed: 26355862
Nucleic Acids Res. 2014 Mar;42(5):e31
pubmed: 24170809
Genes Dev. 2009 Apr 15;23(8):906-11
pubmed: 19390085
Pancreas. 2014 May;43(4):619-23
pubmed: 24658320
Ther Adv Med Oncol. 2022 Mar 15;14:17588359221083050
pubmed: 35309086
Nucleic Acids Res. 2018 Sep 28;46(17):8908-8916
pubmed: 30032250
J Cancer. 2014 Sep 16;5(8):696-705
pubmed: 25258651
Br J Cancer. 2021 Jan;124(2):345-358
pubmed: 32968207

Auteurs

Iris J M Levink (IJM)

Department of Gastroenterology & Hepatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.

Malgorzata I Srebniak (MI)

Department of Clinical Genetics, Erasmus MC, University Medical Center, 3015 CN Rotterdam, The Netherlands.

Walter G De Valk (WG)

Department of Clinical Genetics, Erasmus MC, University Medical Center, 3015 CN Rotterdam, The Netherlands.

Monique M van Veghel-Plandsoen (MM)

Department of Clinical Genetics, Erasmus MC, University Medical Center, 3015 CN Rotterdam, The Netherlands.

Anja Wagner (A)

Department of Clinical Genetics, Erasmus MC, University Medical Center, 3015 CN Rotterdam, The Netherlands.

Djuna L Cahen (DL)

Department of Gastroenterology & Hepatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.

Gwenny M Fuhler (GM)

Department of Gastroenterology & Hepatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.

Marco J Bruno (MJ)

Department of Gastroenterology & Hepatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH